Clinical Trial Update: JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD

View source ↗

Summary

A clinical trial update for JAQBO Tab. 20 mg (Zastaprazan citrate) in erosive gastroesophageal reflux disease; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Gastroesophageal Reflux Disease

Drugs mentioned

• JAQBO Tab. 20 mg (Zastaprazan citrate)

Snippet

Sponsor: Jeil Pharmaceutical Co., Ltd. | Conditions: Erosive Gastroesophageal Reflux Disease | Status: NOT_YET_RECRUITING